— Jeff Ward, Lehigh Valley News Briefs
OraSure, a maker of medical diagnostic kits, will report third-quarter financial results on Nov. 6.
The Bethlehem-based company will report results after the close of regular trading that day, and follow up with a conference call at 5 p.m.
Analysts surveyed by Zacks Investment Research expect a loss of 4 cents per share on sales of $39.15 million. Both numbers are based on the average of just two estimates.
Shares in the maker of InteliSwab tests for COVID-19 and OraQuick, which detects HIV, have been stumbling this year. The closing price Tuesday was $4.09, less than half of the 52-week high of $8.45.
OraSure received government contracts, and funding for a new factory, during the Covid pandemic. The contracts have wound down and revenue has fallen.
Lehigh Valley News Briefs 